FDA Releases Guidance on Residual Solvents in US-Approved Drug Products

Summary

The US Food and Drug Administration (FDA) has made available a guidance document outlining how pharmaceutical companies can comply with new USP standards for controlling residual solvents in drug products marketed in the United States, following a change implemented on July 1, 2008.